KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 91 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,678,000 | -41.7% | 125,000 | -58.3% | 1.10% | -41.2% |
| Q4 2017 | $2,880,000 | -67.2% | 300,000 | -62.5% | 1.88% | -22.5% |
| Q3 2017 | $8,784,000 | +223.5% | 800,000 | +166.7% | 2.42% | +57.8% |
| Q2 2017 | $2,715,000 | -23.1% | 300,000 | +9.1% | 1.54% | -12.1% |
| Q1 2017 | $3,531,000 | – | 275,000 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |